Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Dr. Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Senior Clinical Pharmacist | Beni-Suef University Hospital | Egypt

👩‍🔬 Short Bio:

Selvia Maher Farag Hanna is a dedicated Senior Clinical Pharmacist and Member of the Clinical Research Center at Beni-Suef University Hospital, specializing in Cardiology. With 12 years of experience, she excels in medication therapy management and improving patient outcomes through interdisciplinary collaboration.

Profile:

SCOPUS

📚 Education:

Selvia completed her Doctor of Philosophy in Pharmaceutical Sciences (Clinical Pharmacy) at Beni-Suef University in July 2024. She holds a Master’s degree in Pharmaceutical Sciences (Clinical Pharmacy) and a Bachelor’s degree in Pharmaceutical Sciences, both from Beni-Suef University.

💼 Experience:

Since July 2012, Selvia has served as a Clinical Pharmacist at Beni-Suef University Hospital, focusing on medication management in the Cardiology care unit. Previously, she worked at El-Masrya Pharmacy, gaining experience in medication counseling and drug utilization review.

🔬 Research Interest:

Selvia’s research interests revolve around Cardiology, specifically hypertension management, drug interactions, and patient-centric care strategies to enhance treatment efficacy and safety.

🏆 Award:

Recipient of the Distinguished Scientist Award for her contributions to Clinical Pharmacy and Cardiology research.

📄 Publications:

  1. Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure
    Published in High Blood Pressure & Cardiovascular Prevention, November 2018.
    View Publication
    Cited 11 times.
  2. Effect of Fixed-dose Combination Amlodipine/Valsartan in Comparison to Two Drug Combination Nebivolol/Valsartan on 24-Hour Ambulatory Blood Pressure
    Published in Current Hypertension Reviews, May 2023.
    View Publication
  3. Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers
    Published in Current Hypertension Reviews, September 2022.
  4. Safety and efficacy of candesartan versus valsartan combined with amlodipine on peripheral and central blood pressure
    Published in Hipertension y Riesgo Vascular, January–March 2024.